Bicycle Therapeutics (NASDAQ:BCYC) reported quarterly losses of $(0.74) per share. This is a 10.45 percent decrease over losses of $(0.67) per share from the same period last year. The company reported $1.78 million in sales this quarter. This is a 13.62 percent increase over sales of $1.57 million the same period last year.
Bicycle Therapeutics Q2 EPS $(0.74) Down From $(0.67) YoY, Sales $1.78M Up From $1.57M YoY
Bicycle Therapeutics (NASDAQ:BCYC) reported quarterly losses of $(0.74) per share. This is a 10.45 percent decrease over losses of $(0.67) per share from the same period last year. The company reported $1.78 million in
